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Adherence to and barriers to diabetic eye exams: 
A survey of patients with type 2 diabetes
Daniel Trobare, PharmD Candidate1; Katherine S. 0  'Neal, PharmD, MBA, BCACP, CDE, BC-ADM, AE-C2~3;
Jeremy L. Johnson, PharmD, BCACP, CDE, BC-ADM4, Kevin Farmer, R.Ph., Ph.D., FAPhA1, Angela Boston, PharmD Candidate2 
University of Oklahoma College of Pharmacy-Oklahoma City1, Tulsa2; School o f Community Medicine3; and 
Southwestern Oklahoma State University College of Pharmacy4
Background
• The prevalence of diabetes in the U.S. totals 29.1 million 
people with more than 60% of individuals having some sort of 
retinopathy within the first 20 years of diagnosis.1-2
• Diabetic retinopathy is the most frequent cause of new cases of 
blindness among adults aged 20-74 years.3
Diabetic Retinopathy4 
Prevalance and Projections Millions of cases
• ADA standards recommend annual screening for patients with 
type 2 diabetes to include an initial dilated comprehensive eye 
exam by an optometrist or ophthalmologist. If no disease is 
present after 1 or more exams, then further examinations can 
be considered every two years instead of annually. If 
retinopathy is present, examinations should occur annually. If 
progressing or sight-threatening disease is detected, exams 
are required more frequently.3
• According to the CDC, 50% of patients do not have routine eye 
exams completed or are diagnosed too late for treatment to be 
effective.5
• Because retinopathy is often asymptomatic, routine screening 
is important to detect treatable disease before onset or disease 
progression. Once treatment is needed, visual acuity cannot be 
regained but disease progression can be slowed.3
• It is important to improve the frequency of properly completed 
eye exams. Understanding perceptions of the importance of 
eye exams and barriers to obtaining them may help achieve 
problem resolution.
• Poor health literacy is common among patients with chronic 
conditions. It has also been shown to be associated with a 
higher incidence of retinopathy when compared to patients with 
adequate health literacy.6
• Previous studies have reported common barriers consisting of 
short duration of diabetes, lack of insurance coverage, and 
poor blood glucose control.7
Objective
• To identify potential barriers and perceptions (e.g., knowledge, 
insurance) to comprehensive eye exams from the perspective 
of the patient as well as health literacy, glycemic control, and 
medication adherence.
Methods
• This study has received approval by the University of 
Oklahoma Institutional Review Board
Sample
• 150 randomly selected patients having type 2 diabetes actively 
seen in the OU Physicians Internal Medicine ambulatory care 
clinic in Tulsa, OK
Study Design
• Prospective, observational survey
• Patient barriers assessed  include: eye exam cost, insurance 
status, knowledge about diabetic retinopathy, perceptions, 
health literacy, and overall medication adherence
Study Implementation
• Patients will be surveyed, via telephone or in person, on 
knowledge, perceptions, barriers of utilizing dilated 
comprehensive eye examinations and potential barriers using 
the validated surveys
Survey Components
• 45-item Compliance with Annual Diabetic Eye Exams Survey 
(CADEES)7
• 4-item Morisky-4 Medication Adherence Questionnaire8
• 1-item health literacy screening question9
Statistical Analysis
• A combination of qualitative and quantitative methods will be 
employed for data collection.
• Descriptive statistics will be used to describe patient 
characteristics. Common themes will be identified and reported 
from the qualitative responses.
Survey Tools
CADEES Survey7
• Health belief variables related to the 6 constructs of the 
Health Belief Model (severity, susceptibility, benefits, barriers, 
cues to action, and self efficacy)
• Adherence items (e.g., satisfaction with eye care provider 
and depression)
• 13 clinical and demographic items, 1 yes-or-no question,
1 open-ended question, and 43 health belief statements
Moriskv-4 Medication Adherence Questionnaire8
1. Do you ever forget to take your medicine?
2. Are you careless at times about taking your medicine?
3. When you feel better, do you sometimes stop taking your 
medicine?
4. Sometimes if you feel worse when you take the medicine, do 
you stop taking it?
1- item health literacy screening question
• How confident are you filling out medical forms by yourself?
(.Extremely; Quite a bit, Somewhat, A little bit, Not at all)
Future Direction
• Findings may inform investigators of local barriers to and 
perceptions of dilated comprehensive eye examinations for 
patients with type 2 diabetes.
• Once barriers have been identified, methods may be devised 
to improve utilization and ultimately patient safety and clinical 
outcomes.
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